In a Phase I/II trial, convection-enhanced delivery of an engineered poliovirus yielded similar median overall survival compared to historical controls. However, a small subgroup of treated patients had extended survival past two years.
ABSTRACT & COMMENTARY
Viral Therapy for Glioblastoma
August 1, 2018